510(k) device
Cytal® Wound Matrix
Acell, Inc. · Wound Dressing With Animal-Derived Material(S) (KGN, Unclassified) · First FDA decision Dec 8, 2015, newest Jul 11, 2024BurnsChronic wounds and ulcers
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
4
510(k) pathway
Device trials
7
Naming "Cytal"
MAUDE reports
8
Brand "Cytal", since 2015
PubMed studies
8
Mentioning "Cytal"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Cytal® Wound Matrix
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 4 of 4 decisions filed under this name.
K241724 · Decided Jul 11, 2024 · 27 days after receipt
Device type: Wound Dressing With Animal-Derived Material(S) (KGN) · General & Plastic Surgery
K192725 · Decided Oct 25, 2019 · 28 days after receipt
Device type: Wound Dressing With Animal-Derived Material(S) (KGN) · General & Plastic Surgery
- Cytal Wound Particulate510(k)
K180776 · Decided May 11, 2018 · 49 days after receipt
Device type: Wound Dressing With Animal-Derived Material(S) (KGN) · General & Plastic Surgery
1 more FDA decisions with a free account
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "Cytal", any status and sponsor, newest update first.
- The Management of Necrotizing Soft Tissue Infection Wounds With Cytal® Wound Matrix and MicroMatrix®Recruiting
Benjamin T. MillerAcademic, hospital or other
NCT06857708 · 50 participants (planned) · Start Mar 5, 2025 · Primary completion Sep 1, 2028
Device: Cytal® Wound Matrix; MicroMatrix® · For: Necrotizing Fascitis; Necrotizing Soft Tissue Infection
Sites: Cleveland, Ohio
Integra LifeSciences CorporationPublic (IART)
NCT06629506 · 25 participants · Start Dec 12, 2024 · Primary completion Aug 31, 2025
Device: MicroMatrix® Flex; MicroMatrix® UBM Particulate and 1 more · For: Pressure Injury; Venous Ulcer; Necrotizing Soft Tissue Infection and 2 more
Sites: Aurora, Colorado; Washington D.C., District of Columbia; Lake Success, New York
Integra LifeSciences CorporationPublic (IART)
NCT03626623 · 15 participants · Start May 21, 2019 · Primary completion Feb 18, 2020
Device: Cytal Wound Matrix 1-Layer · For: Diabetes; Diabetic Foot; Diabetes Mellitus, Type 2 and 1 more
Sites: Fresno, California; New Orleans, Louisiana; Hyattsville, Maryland
4 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Cytal", and for the whole product code for context.
This brand
8 reports: 4 malfunction, 4 injury, 0 death
Whole product code KGN
154 reports: 32 malfunction, 117 injury, 1 death
Newest reports for this brand
- CYTAL WOUND MATRIX - 2 LAYER 10 X 15 CMMalfunction
3005920706-2026-00030 · Received Apr 17, 2026 · Event dated Mar 25, 2026
Device type: Wound Dressing With Animal-Derived Material(S) (KGN)
Device problem as coded: Adverse Event Without Identified Device or Use Problem
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
3005920706-2026-00024 · Received Mar 20, 2026
Device type: Wound Dressing With Animal-Derived Material(S) (KGN)
Device problem as coded: Insufficient Device Problem Information
Patient problem as coded: Granuloma; Exostosis (bone)
- UNKNOWN CYTAL WOUND MATRIXMalfunction
3005920706-2025-00017 · Received Sep 5, 2025
Device type: Wound Dressing With Animal-Derived Material(S) (KGN)
Device problem as coded: Patient Device Interaction Problem
Patient problem as coded: Insufficient Information
2 more reports with a free account
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
- Cytal Wound Matrix 2-Layer 5x5 cm. Product ID: WSM0505.Open, Classified
Integra LifeSciences Corp. (NeuroSciences)
Z-1816-2026 · Started Mar 19, 2026 · Posted by FDA Apr 15, 2026
Reason given: Increased rate of out-of-specification endotoxin results.
Cause as FDA categorized it: Under Investigation by firm · Device type: Wound Dressing With Animal-Derived Material(S) (KGN)
- Cytal Wound Matrix 2-Layer 7x10 cm. Product ID: WSM0710.Open, Classified
Integra LifeSciences Corp. (NeuroSciences)
Z-1817-2026 · Started Mar 19, 2026 · Posted by FDA Apr 15, 2026
Reason given: Increased rate of out-of-specification endotoxin results.
Cause as FDA categorized it: Under Investigation by firm · Device type: Wound Dressing With Animal-Derived Material(S) (KGN)
- Cytal Wound Matrix 2-Layer 10x15 cm. Product ID: WSM1015.Open, Classified
Integra LifeSciences Corp. (NeuroSciences)
Z-1818-2026 · Started Mar 19, 2026 · Posted by FDA Apr 15, 2026
Reason given: Increased rate of out-of-specification endotoxin results.
Cause as FDA categorized it: Under Investigation by firm · Device type: Wound Dressing With Animal-Derived Material(S) (KGN)
2 more recall records with a free account
Published research
The most relevant PubMed records for "Cytal"[tiab]. The summary above synthesizes these.
- Management of Ankle Fracture Wounds Using Urinary Bladder Matrix: A Case Report.
Alenizi M, Tarabishi M, Alayed F, et al. · Cureus · 2024Case Reports
- Single-Layer Acellular Porcine Bladder Matrix as Graft in Corporoplasty for Ventral Curvature in Pediatric Proximal Hypospadias Repair: An Initial Experience.
Huen KH, Macaraeg A, Davis-Dao CA, et al. · Urology · 2022
- Use of Biologic Agents in Nasal and Scalp Reconstruction.
Depani M, Grush AE, Parham MJ, et al. · Semin Plast Surg · 2022Review
- Diuretic effects of irrigating fluids containing mannitol and sorbitol.
Zhang W, Hahn RG · Scand J Urol Nephrol · 1995Research Support, Non-U.S. Gov't
- [Growth modulating and cytotoxic effects of the peptide from hemolymph of blow fly Calliphora vicina (Diptera, Calliphoridae) in vitro].
Pleskach VA, Kozhukharova IV, Artsybasheva IV, et al. · Tsitologiia · 2010English Abstract, Research Support, Non-U.S. Gov't
- Calcaneus Wound Healing With the Aid of Urinary Bladder Matrix (UBM).
Alalwan T, Tarabishi M, Akkad L, et al. · Cureus · 2026Case Reports
- Intravenous infusions of 10 per cent cytal, 5 per cent dextrose water, or plavolex in dogs.
MARX GF, ROTHAUS R, ORKIN LR · J Urol · 1960
- Clinical use of cytal in urology.
SCHULTE TL, HAMMER HJ, REYNOLDS LR · J Urol · 1954
Other devices of this type
Also filed under product code KGN.
- PriMatrix Dermal Repair ScaffoldTei Biosciences, Inc. · 510(k) 2016
- Marigen Wound ExtraKerecis Limited · 510(k) 2025
- MatriDermMedskin Solutions Dr. Suwelack AG · 510(k) 2026
- CollOvine Wound PowderOvigenex, LLC · 510(k) 2026
- SurgiAid Collagen Wound Dressing (HA)Maxigen Biotech, Inc. · 510(k) 2025
- Collagen Wound DressingWinner Medical Co., Ltd. · 510(k) 2025
- Corplex P/ Theracor P/ Allacor PStimlabs, LLC · 510(k) 2024
- Foundation Dermal Regeneration Scaffold (DRS) SoloBionova Medical, Inc. · 510(k) 2023
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.